Impact of Elagolix on Workplace and Household Productivity Among Women with Moderate to Severe Pain Associated with Endometriosis: A Pooled Analysis of Two Phase III Trials.
Patient
; 12(6): 651-660, 2019 12.
Article
en En
| MEDLINE
| ID: mdl-31654294
ABSTRACT
BACKGROUND:
Endometriosis profoundly impairs women's workplace and household productivity.OBJECTIVE:
The aim of this study was to evaluate the impact of elagolix on endometriosis-related workplace and household productivity losses.METHODS:
Data were pooled from two phase III trials of women aged 18-49 years with moderate to severe endometriosis-associated pain treated for 6 months with elagolix 150 mg daily (QD), 200 mg twice daily (BID), or placebo. The Health-Related Productivity Questionnaire was administered at baseline, Month 3, and Month 6 to determine workplace and household absenteeism and presenteeism. Productivity changes from baseline were compared between placebo and elagolix doses via analysis of covariance.RESULTS:
Workplace analyses included 1270 employed women and household analyses included 1565 women. At baseline, women reported average weekly losses of 16 workplace hours, 8.3 household work hours, 45% of scheduled work, and 64% of planned household chores. At Month 6, treatment with elagolix 150 mg QD or 200 mg BID increased productive workplace hours by 1.7 (95% CI 0.1-3.4; p = 0.041) and 5.4 h (95% CI 3.7-7.1; p < 0.001) relative to placebo, corresponding to gains of 5.2% (95% CI 0.7-9.7; p = 0.022) and 14.6% (95% CI 10.0-19.1; p < 0.001) of scheduled work, respectively. Both elagolix doses improved household productivity at Month 6 by 1.7 (95% CI 0.7-2.7) and 3.1 (95% CI 2.1-4.0) hours relative to placebo (both p < 0.001), with increases of 8.8% (95% CI 3.5-14.1; p = 0.001) and 20.4% (95% CI 15.1-25.6; p < 0.001) of planned household work.CONCLUSIONS:
Treatment with elagolix improved endometriosis-related workplace and household productivity impairments. TRIAL REGISTRATION ELARIS EM-I (NCT01620528) and ELARIS EM-II (NCT01931670).
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Dolor
/
Pirimidinas
/
Análisis y Desempeño de Tareas
/
Composición Familiar
/
Lugar de Trabajo
/
Ensayos Clínicos Fase III como Asunto
/
Endometriosis
/
Hidrocarburos Fluorados
Tipo de estudio:
Clinical_trials
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Patient
Año:
2019
Tipo del documento:
Article
País de afiliación:
Estados Unidos